Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin’s lymphoma: a single-centre study of 20 patients

By Aydin Semra   Dührsen Ulrich   Nückel Holger  

Annals of Hematology, Vol. 86, Iss. 4, 2007-04 ,pp. : 271-276

Springer Publishing Company

Access to resources Recommend Favorite

FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin’s lymphoma and Hodgkin’s disease

By Querellou Solène   Valette Frédéric   Bodet-Milin Caroline   Oudoux Aurore   Carlier Thomas   Harousseau Jean-Luc   Chatal Jean-François   Couturier Olivier  

Annals of Hematology, Vol. 85, Iss. 11, 2006-11 ,pp. : 759-767

Springer Publishing Company

Access to resources Recommend Favorite

Analysis of clinical characteristics, diagnosis, treatment and prognosis of 46 patients with primary gastrointestinal nonHodgkin lymphoma

By          

Molecular and Clinical Oncology, Vol. 2, Iss. 2, 2014-01 ,pp. : 259-264

Spandidos Publications

Access to resources Recommend Favorite

High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin’s lymphoma

By Chen Ming-Huang  

Annals of Hematology, Vol. 87, Iss. 6, 2008-06 ,pp. : 475-480

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic factors of Chinese patients with primary pulmonary non-Hodgkin's lymphoma: the single-institute experience in Taiwan

By Hu Yu-Hui  

Annals of Hematology, Vol. 88, Iss. 9, 2009-09 ,pp. : 839-846

Springer Publishing Company

Access to resources Recommend Favorite